These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3080551)

  • 1. Phase I trial of recombinant interferon gamma in cancer patients.
    Vadhan-Raj S; Al-Katib A; Bhalla R; Pelus L; Nathan CF; Sherwin SA; Oettgen HF; Krown SE
    J Clin Oncol; 1986 Feb; 4(2):137-46. PubMed ID: 3080551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of recombinant interferon gamma by 1-hour i.v. infusion.
    Vadhan-Raj S; Nathan CF; Sherwin SA; Oettgen HF; Krown SE
    Cancer Treat Rep; 1986 May; 70(5):609-14. PubMed ID: 3085930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients.
    Kurzrock R; Rosenblum MG; Quesada JR; Sherwin SA; Itri LM; Gutterman JU
    J Clin Oncol; 1986 Nov; 4(11):1677-83. PubMed ID: 3095504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of i.v. administered recombinant gamma interferon in cancer patients.
    Kurzrock R; Quesada JR; Rosenblum MG; Sherwin SA; Gutterman JU
    Cancer Treat Rep; 1986 Dec; 70(12):1357-64. PubMed ID: 3098417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of combinations of recombinant interferons beta(ser) and gamma in patients with advanced malignancy.
    Schiller JH; Storer B; Willson JK; Borden EC
    Cancer Treat Rep; 1987 Oct; 71(10):945-52. PubMed ID: 3115570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
    Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC
    Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.
    Ernstoff MS; Nair S; Bahnson RR; Miketic LM; Banner B; Gooding W; Day R; Whiteside T; Hakala T; Kirkwood JM
    J Clin Oncol; 1990 Oct; 8(10):1637-49. PubMed ID: 2120392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of multiple dose intramuscularly administered recombinant gamma interferon.
    Kurzrock R; Quesada JR; Talpaz M; Hersh EM; Reuben JM; Sherwin SA; Gutterman JU
    J Clin Oncol; 1986 Jul; 4(7):1101-9. PubMed ID: 3088221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I trial of recombinant interleukin-2 combined with recombinant interferon-gamma in patients with cancer.
    Redman BG; Flaherty L; Chou TH; al-Katib A; Kraut M; Martino S; Chen B; Kaplan J; Valdivieso M
    J Clin Oncol; 1990 Jul; 8(7):1269-76. PubMed ID: 2113571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy.
    Perez R; Lipton A; Harvey HA; Simmonds MA; Romano PJ; Imboden SL; Giudice G; Downing MR; Alton NK
    J Biol Response Mod; 1988 Jun; 7(3):309-17. PubMed ID: 3134513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant interferon-gamma (immuneron): results of a phase I trial in patients with cancer.
    van der Burg M; Edelstein M; Gerlis L; Liang CM; Hirschi M; Dawson A
    J Biol Response Mod; 1985 Jun; 4(3):264-72. PubMed ID: 3926954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 1 study of recombinant interferon-gamma given intravenously by portable mini-pump: a preliminary report.
    Sriskandan K; Garner P; Watkinson J; Gerlis L; Tee DE
    Int J Clin Pharmacol Res; 1984; 4(6):469-74. PubMed ID: 6241930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma.
    Ernstoff MS; Trautman T; Davis CA; Reich SD; Witman P; Balser J; Rudnick S; Kirkwood JM
    J Clin Oncol; 1987 Nov; 5(11):1804-10. PubMed ID: 3119786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I clinical trial of recombinant DNA gamma interferon.
    Brown TD; Koeller J; Beougher K; Golando J; Bonnem EM; Spiegel RJ; Von Hoff DD
    J Clin Oncol; 1987 May; 5(5):790-8. PubMed ID: 3106584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patients.
    Boue F; Pastran Z; Spielmann M; Le Chevalier T; Subirana R; Sevin D; Paoletti C; Brandely M; Avril MF; Sancho-Garnier H
    Cancer Immunol Immunother; 1990; 32(1):67-70. PubMed ID: 2126985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase I study of a recombinant gamma interferon (S-6810)].
    Ogawa M; Takaku F; Maekawa T; Ota K; Ichimaru M; Izuo M; Takakura K; Ikeda S; Koiso K; Machida T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):446-52. PubMed ID: 3101608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer.
    Sherwin SA; Foon KA; Abrams PG; Heyman MR; Ochs JJ; Watson T; Maluish A; Oldham RK
    J Biol Response Mod; 1984 Dec; 3(6):599-607. PubMed ID: 6439828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Southwest Oncology Group Phase I study of the sequential combination of recombinant interferon-gamma and recombinant interleukin-2 in patients with cancer.
    Taylor CW; Chase EM; Whitehead RP; Rinehart JJ; Neidhart JA; Gonzalez R; Bunn PA; Hersh EM
    J Immunother (1991); 1992 Apr; 11(3):176-83. PubMed ID: 1515422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase I-II study of recombinant interferon gamma].
    Adachi K; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Nakada H; Tada A; Yamazaki H; Mukaiyama T
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1331-8. PubMed ID: 2988459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human gamma interferon administered by continuous intravenous infusion in acute myelogenous leukemia and myelodysplastic syndromes.
    Stone RM; Spriggs DR; Arthur KA; Mayer RJ; Griffin J; Kufe DW
    Am J Clin Oncol; 1993 Apr; 16(2):159-63. PubMed ID: 8452111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.